BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 27058526)

  • 1. Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models.
    Kimura N
    Int J Mol Sci; 2016 Apr; 17(4):503. PubMed ID: 27058526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes mellitus accelerates Aβ pathology in brain accompanied by enhanced GAβ generation in nonhuman primates.
    Okabayashi S; Shimozawa N; Yasutomi Y; Yanagisawa K; Kimura N
    PLoS One; 2015; 10(2):e0117362. PubMed ID: 25675436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease.
    Ramos-Rodriguez JJ; Jimenez-Palomares M; Murillo-Carretero MI; Infante-Garcia C; Berrocoso E; Hernandez-Pacho F; Lechuga-Sancho AM; Cozar-Castellano I; Garcia-Alloza M
    Psychoneuroendocrinology; 2015 Dec; 62():69-79. PubMed ID: 26254770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type II Diabetes Mellitus Accelerates Age-Dependent Aβ Pathology in Cynomolgus Monkey Brain.
    Kimura N
    Adv Exp Med Biol; 2019; 1128():133-145. PubMed ID: 31062328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
    Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
    Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Galindo-Gonzalez L; Garcia-Alloza M
    Psychoneuroendocrinology; 2016 Mar; 65():15-25. PubMed ID: 26708068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New animal models of Alzheimer's disease that display insulin desensitization in the brain.
    Gao C; Liu Y; Li L; Hölscher C
    Rev Neurosci; 2013; 24(6):607-15. PubMed ID: 24259244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of insulin signaling in the interaction between Alzheimer disease and diabetes mellitus: a missing link to therapeutic potential.
    Sato N; Takeda S; Uchio-Yamada K; Ueda H; Fujisawa T; Rakugi H; Morishita R
    Curr Aging Sci; 2011 Jul; 4(2):118-27. PubMed ID: 21235496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function.
    Takeda S; Sato N; Rakugi H; Morishita R
    Mol Biosyst; 2011 Jun; 7(6):1822-7. PubMed ID: 21431241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?
    Stanley M; Macauley SL; Holtzman DM
    J Exp Med; 2016 Jul; 213(8):1375-85. PubMed ID: 27432942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and Molecular Mechanisms of Dementia: Decoding the Causal link of Diabetes Mellitus in Alzheimer's Disease.
    Rasool M; Malik A; Waquar S; Zaheer A; Asif M; Iqbal Z; Gauthaman K; Kamal MA; Pushparaj PN
    CNS Neurol Disord Drug Targets; 2021; 20(7):602-612. PubMed ID: 33583389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
    Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
    Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-β and tau pathology of Alzheimer's disease induced by diabetes in a rabbit animal model.
    Bitel CL; Kasinathan C; Kaswala RH; Klein WL; Frederikse PH
    J Alzheimers Dis; 2012; 32(2):291-305. PubMed ID: 22785400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of insulin resistance in Alzheimer's disease.
    Cai Z; Xiao M; Chang L; Yan LJ
    Metab Brain Dis; 2015 Aug; 30(4):839-51. PubMed ID: 25399337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse models of Alzheimer's disease: the long and filamentous road.
    Phinney AL; Horne P; Yang J; Janus C; Bergeron C; Westaway D
    Neurol Res; 2003 Sep; 25(6):590-600. PubMed ID: 14503012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
    Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
    J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
    Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
    Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Alzheimer's amyloid-beta and tau protein on mitochondrial function -- role of glucose metabolism and insulin signalling.
    Rhein V; Eckert A
    Arch Physiol Biochem; 2007 Jun; 113(3):131-41. PubMed ID: 17922309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axonopathy Likely Initiates Neuropathological Processes Via a Mechanism of Axonal Leakage in Alzheimer's Mouse Models.
    Gao G; He J; Luo Y; Sun Y; Zhou Y; Zhang J; Xing Y; Dai J
    Curr Mol Med; 2019; 19(3):183-195. PubMed ID: 30961496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.